hotspot -WSS

hotspot

author：fashion 2025-10-02 22:56:44 - browse：76286

People in business and medical wardrobe in a table discussion — coverage from STAT — Adobe

R1 RCM, a large publicly traded technology company that helps hospitals and physicians collect money from insurers and patients, may be going private.

Private equity firm New Mountain Capital has offered to purchase R1 for $13.75 per share, or roughly $5.8 billion in cash, according to new financial disclosures filed Monday. New Mountain Capital is R1’s second-largest investor, owning nearly one-third of the company’s shares.

In response to the offer, R1 asked New Mountain Capital to “engage in good faith discussions” with its largest investor — a partnership between Ascension, the large Catholic hospital system, and private equity firm TowerBrook Capital Partners. New Mountain Capital has since held several in-person meetings with Ascension and TowerBrook throughout February, but maintained its original offer for R1. No deal has been finalized yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Study on Amgen’s bispecific immunotherapy produces positive data

WSS

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Is there really a nursing shortage in the U.S.?

Francis Collins on trust in science and how Covid communications failed

Eli Lilly, Pfizer, and others want in on the online prescription market

Research misconduct: Proposed new rules face resistance

Cassava Sciences’ Alzheimer’s clinical trials should be halted

knowledge

hotspot

focus

Psychedelics group wrestles with new pharma identity

Results on Novartis prostate cancer therapy could expand its use

Jerome Adams on the need for new antivirals for Covid

Readout Newsletter: Merck, J&J, and long Covid

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Novavax promises a turnaround & Lilly roils the obesity market

STAT Readout Newsletter: Biotech news today

Cancer drug shortages should be causing more outrage

J&J lung cancer data amount to new salvo against AstraZeneca

focus

Dewpoint Therapeutics lays off staff after losing partnerships

Roche acquires Telavant from Roivant, adding experimental IBD treatment

How digital therapeutics firms are pivoting after Pear's bankruptcy

Readout LOUD podcast: Live from the 2023 STAT Summit

J&J lung cancer data amount to new salvo against AstraZeneca

STAT Readout Newsletter: Biotech news today

leisure time

focus

hotspot

explore